Literature DB >> 11035718

Phagocytosis and protein processing are required for presentation of Cryptococcus neoformans mitogen to T lymphocytes.

R M Syme1, J C Spurrell, L L Ma, F H Green, C H Mody.   

Abstract

In addition to eliciting antigen specific T-cell-mediated immunity, Cryptococcus neoformans possesses a mitogen (CnM) that activates naive T cells to proliferate. This mechanism of T-cell activation is accessory cell dependent and major histocompatibility complex unrestricted. CnM-induced T-cell proliferation correlates with internalization of the organism, suggesting that intracellular processing is required to liberate CnM prior to presentation to T cells. To determine whether phagocytosis and processing are required, various inhibitors of accessory cell uptake and processing were used. C. neoformans was observed within the accessory cells. Paraformaldehyde fixation of the accessory cell abrogated presentation of CnM to T cells, indicating that a dynamic accessory cell surface was required. A lysosomotropic agent abrogated the response to CnM but had no effect on a control stimulus that did not require processing. Both aspartic acid and cysteine protease inhibitors blocked effective processing of CnM, so that it was unable to stimulate T cells. Finally, an inhibitor of microfilament polymerization abrogated proliferation to CnM. These results indicate that the mitogenic activity of C. neoformans requires phagocytosis of the organism, lysosomal or endosomal processing, proteolytic activity, and microfilament polymerization and intracellular transport as a prerequisite for T-cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035718      PMCID: PMC97692          DOI: 10.1128/IAI.68.11.6147-6153.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

1.  Differential ability of fixed antigen-presenting cells to stimulate nominal antigen-reactive and alloreactive T4 lymphocytes.

Authors:  J Moreno; P E Lipsky
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

2.  Studies on the accessory requirement for T lymphocyte activation by concanavalin A.

Authors:  R B Gallagher; A Whelan; C Feighery
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

3.  A group-specific inhibitor of lysosomal cysteine proteinases selectively inhibits both proteolytic degradation and presentation of the antigen dinitrophenyl-poly-L-lysine by guinea pig accessory cells to T cells.

Authors:  S Buus; O Werdelin
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

4.  T cell recognition of fibrinogen. A determinant on the A alpha-chain does not require processing.

Authors:  P Lee; G R Matsueda; P M Allen
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

Review 5.  T-cell recognition of lysozyme: the biochemical basis of presentation.

Authors:  P M Allen; B P Babbitt; E R Unanue
Journal:  Immunol Rev       Date:  1987-08       Impact factor: 12.988

6.  Accessory cell functions of dendritic cells and macrophages in the thymic T-cell response to Con A.

Authors:  Y Hirayama; K Inaba; S Komatsubara; K Yoshida; J Kawai; K Naito; S Muramatsu
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

7.  Cytochalasin B enhances T cell mitogenesis by promoting expression of an interleukin 2 receptor.

Authors:  H Komada; H Nakabayashi; M Idota; M Hara; T Takahashi; H Takanari; K Izutsu
Journal:  Cell Struct Funct       Date:  1987-06       Impact factor: 2.212

8.  Cyclosporin A inhibits the growth of Cryptococcus neoformans in a murine model.

Authors:  C H Mody; G B Toews; M F Lipscomb
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

9.  Augmentation of interleukin-2 release by cytochalasins.

Authors:  M A Valentine; J A Vaughan
Journal:  Cell Immunol       Date:  1986-09       Impact factor: 4.868

10.  The capsule of Cryptococcus neoformans reduces T-lymphocyte proliferation by reducing phagocytosis, which can be restored with anticapsular antibody.

Authors:  R M Syme; T F Bruno; T R Kozel; C H Mody
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

View more
  16 in total

1.  Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans.

Authors:  Neena Jain; Li Li; Ye-Ping Hsueh; Abraham Guerrero; Joseph Heitman; David L Goldman; Bettina C Fries
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

2.  Cryptococcus neoformans-induced macrophage lysosome damage crucially contributes to fungal virulence.

Authors:  Michael J Davis; Alison J Eastman; Yafeng Qiu; Brian Gregorka; Thomas R Kozel; John J Osterholzer; Jeffrey L Curtis; Joel A Swanson; Michal A Olszewski
Journal:  J Immunol       Date:  2015-01-30       Impact factor: 5.422

3.  Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection.

Authors:  B C Fries; C P Taborda; E Serfass; A Casadevall
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

4.  Heparin enhances uptake of platelet factor 4/heparin complexes by monocytes and macrophages.

Authors:  M Joglekar; S Khandelwal; D B Cines; M Poncz; L Rauova; G M Arepally
Journal:  J Thromb Haemost       Date:  2015-07-14       Impact factor: 5.824

5.  ATG Genes Influence the Virulence of Cryptococcus neoformans through Contributions beyond Core Autophagy Functions.

Authors:  Hao Ding; Mélissa Caza; Yifei Dong; Arif A Arif; Linda C Horianopoulos; Guanggan Hu; Pauline Johnson; James W Kronstad
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

6.  Tumor cell-released autophagosomes (TRAP) enhance apoptosis and immunosuppressive functions of neutrophils.

Authors:  Rong Gao; Jie Ma; Zhifa Wen; Peiying Yang; Jinjin Zhao; Meng Xue; Yongqiang Chen; Mohanad Aldarouish; Hong-Ming Hu; Xue-Jun Zhu; Ning Pan; Li-Xin Wang
Journal:  Oncoimmunology       Date:  2018-03-06       Impact factor: 8.110

7.  Melanization of Cryptococcus neoformans affects lung inflammatory responses during cryptococcal infection.

Authors:  Aron J Mednick; Joshua D Nosanchuk; Arturo Casadevall
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 8.  Role of dendritic cell-pathogen interactions in the immune response to pulmonary cryptococcal infection.

Authors:  Alison J Eastman; John J Osterholzer; Michal A Olszewski
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

9.  Phenotypic switching in Cryptococcus neoformans contributes to virulence by changing the immunological host response.

Authors:  Abraham Guerrero; Bettina C Fries
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

10.  Antibodies generated against conserved antigens expressed by bacteria and allergen-bearing fungi suppress airway disease.

Authors:  Nicholas W Kin; Emily K Stefanov; Brian L P Dizon; John F Kearney
Journal:  J Immunol       Date:  2012-07-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.